Rybelsus® for Weight Loss | Achieve Health & Weight Loss

Rybelsus® for Weight Loss

A Needle-Free GLP-1 Option for Blood Sugar and Weight Management.

Rybelsus® is the first and only GLP-1 receptor agonist available in a pill form, making it an excellent choice for those who prefer to avoid injections. It is approved for adults with type 2 diabetes to help regulate blood sugar levels and has also been shown to support weight loss. It is used off-label for weight management. 

See if you qualify

The Science Behind Z Rybelsus® for Weight Loss

Rybelsus® mimics glucagon-like peptide-1 (GLP-1), a natural hormone that helps control blood sugar and appetite. By stimulating insulin production when blood sugar is high, slowing digestion, and reducing hunger, Rybelsus® can lead to better glycemic control and weight loss.

Clinical studies have shown that Rybelsus® offers multiple health benefits:

✔ Improved Blood Sugar Control

Many users experience lower A1C levels, with some achieving reductions of 1-2% over time.

✔ Weight Loss Support

Participants in studies lost an average of 5 to 8 pounds, or MORE over 6 months, especially when combined with the Achieve medical weight management program.

✔ No Needles Required

Unlike Mounjaro®, Ozempic®, or Wegovy®, which require weekly injections, Rybelsus® is taken as a once-daily pill, making it ideal for those uncomfortable with needles.

What to Expect

Many patients report positive outcomes, including weight loss, better energy levels, and improved metabolic health. However, as with any medication, side effects can occur. The most common include:

    • Mild nausea – Often temporary and improves with time.
    • Decreased appetite – May contribute to weight loss.
    • Digestive issues – Some users experience bloating or changes in bowel habits.

These side effects tend to lessen as your body adjusts to the medication.

Is Rybelsus® Right for You?

If you’re looking for a needle-free option for weight management, Rybelsus® may be a great fit.

Achieve Weight Loss Program Availability

Achieve Health and Weight Loss programs are available in the follow states:

Alabama
Arizona
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Michigan
Minnesota
Mississippi
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New York
North Dakota
Ohio
Oklahoma
Pennsylvania
South Dakota
Tennessee
Texas
Utah
Vermont
Washington
West Virginia
Wisconsin
Wyoming

Alternative GLP-1 and GIP/GLP-1 Medications

Zepbound®

A once-weekly injectable Tirzepatide, a dual GLP-1 and GIP receptor agonist, indicated for Type 2 diabetes and approved for weight loss management.

Tirzepatide

A once-weekly injectable GLP-1 and GIP receptor agonist, similar to Mounjaro/Zepbound, compounded for weight loss and diabetes management.

Semaglutide

A once-weekly injectable GLP-1 receptor agonist that mirrors the active ingredient in Wegovy/Ozempic, typically compounded for cost-effective weight loss management.

Wegovy®

A once-weekly injectable GLP-1 receptor agonist (Semaglutide) specifically approved for chronic weight management in adults with obesity or overweight.

Ozempic®

A once-weekly injectable GLP-1 indicated for the treatment of Type 2 diabetes, and is safe and effective for weight loss.

Mounjaro®

A once-weekly injectable GLP-1 and GIP receptor agonist indicated for the treatment of Type 2 diabetes and is safe and effective for weight loss.

Transform Your Body, Transfom Your Life!

It’s time to step away from impersonal chatbots and algorithmic goal-setting. Say hello to premier care where our dedicated personal coaches are eager to provide virtual support every step of the way. Whether you experience victories, setbacks, or comebacks, our coaches will be there to lend a helping hand and guide you towards success.

20% Average
Weight Loss

GLP-1 and GIP/GLP-1
medication

Holistic
Program

Get Started
Scroll to Top